Rating Change
Barclays analysts downgraded Qiagen N.V. (NYSE:QGEN) from Overweight to Equal-Weight on October 28, 2026.
downgradeNYSE:QGEN
Qiagen N.V. (QGEN) Downgraded to Equal-Weight by Barclays
Barclays analysts downgraded Qiagen N.V. (NYSE:QGEN) from Overweight to Equal-Weight on October 28, 2026.
At publication ·
What changed
Qiagen N.V. (NYSE:QGEN) · downgrade
- Firm
- Barclays
- Rating
- Overweight to Equal-Weight
- Price at event
- $50.33
- Market capitalization
- $9.8B
At a glance
Key takeaways
- Barclays downgraded Qiagen from Overweight to Equal-Weight on October 28, 2026, potentially prompting institutional investor position adjustments.
Market Context
Qiagen N.V. operates in the Healthcare sector. The stock currently trades at $50.33 with a market capitalization of $9.8B. The stock has gained 8.6% over the past 52 weeks.
Analyst downgrades can weigh on a stock in the short term as institutional investors who follow Barclays's research adjust their positions. However, downgrades also sometimes create buying opportunities if the market overreacts to the rating change. The reasoning behind the downgrade matters more than the rating itself.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Qiagen N.V.
Among the 10 most recent ratings: 4 Buy, 6 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 28, 2026 | Barclays | Equal-Weight | N/A |
| Oct 26, 2026 | Citigroup | Neutral | N/A |
| Oct 22, 2026 | JP Morgan | Neutral | N/A |
| Oct 22, 2026 | Baird | Outperform | N/A |
| Oct 14, 2026 | JP Morgan | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View QGEN Stock Page
Frequently Asked Questions
What does the Equal-Weight rating mean for QGEN?
A rating of Equal-Weight from Barclays reflects the analyst's outlook on Qiagen N.V. (NYSE:QGEN). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the QGEN forecast page.